
GC62128
Bractoppin
Also known as [4-[(2-fluorophenyl)methyl]piperazin-1-yl]-(2-phenyl-3H-benzimidazol-5-yl)methanone
Bractoppin is a tandem BRCT (tandem BRCT, BRCA1) delivered by human breast and ovarian cancer suppressor protein (BRCA1) tBRCT domain recognizes a drug-like inhibitor of phosphopeptide that selectively inhibits nanomolar activity of substrate binding in vitro with an IC50 of 0·074 μM
ChemicalCAS2290527-07-8MW414.47FormulaC25H23FN4O
- CAS number
- 2290527-07-8
- Molecular weight
- 414.47
- Formula
- C25H23FN4O
- Solubility
- DMSO : 250 mg/mL (603·18 mM; Need ultrasonic)
- InChIKey
- UHDGSNOZRAAGIZ-UHFFFAOYSA-N
- Catalogue number
- GC62128
- Brand
- GLPBIO
Computed properties PubChem CID 137519541 · XLogP 4 · TPSA 52.2 Ų · H-bond donors 1
- XLogP
- 4
- TPSA
- 52.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 31
SMILES C1CN(CCN1CC2=CC=CC=C2F)C(=O)C3=CC4=C(C=C3)N=C(N4)C5=CC=CC=C5
Computed descriptors from PubChem (CID 137519541), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il